JP2006510711A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2006510711A5 JP2006510711A5 JP2004562109A JP2004562109A JP2006510711A5 JP 2006510711 A5 JP2006510711 A5 JP 2006510711A5 JP 2004562109 A JP2004562109 A JP 2004562109A JP 2004562109 A JP2004562109 A JP 2004562109A JP 2006510711 A5 JP2006510711 A5 JP 2006510711A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- leucine
- weight
- composition according
- proteinaceous material
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 claims description 32
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 claims description 19
- 229960003136 leucine Drugs 0.000 claims description 19
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 claims description 18
- 239000000463 material Substances 0.000 claims description 11
- 229940024606 amino acid Drugs 0.000 claims description 9
- 150000001413 amino acids Chemical class 0.000 claims description 9
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 claims description 4
- 102000004169 proteins and genes Human genes 0.000 claims description 4
- 108090000623 proteins and genes Proteins 0.000 claims description 4
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 claims description 3
- 229960000310 isoleucine Drugs 0.000 claims description 3
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 claims description 3
- 229960004295 valine Drugs 0.000 claims description 3
- 230000001195 anabolic effect Effects 0.000 claims description 2
- 150000001720 carbohydrates Chemical class 0.000 claims description 2
- 230000001939 inductive effect Effects 0.000 claims description 2
- 150000002632 lipids Chemical class 0.000 claims description 2
- 235000001014 amino acid Nutrition 0.000 claims 7
- 239000003795 chemical substances by application Substances 0.000 claims 6
- 150000002016 disaccharides Chemical class 0.000 claims 3
- 235000013305 food Nutrition 0.000 claims 3
- 150000002772 monosaccharides Chemical class 0.000 claims 3
- 108090000765 processed proteins & peptides Proteins 0.000 claims 3
- 235000018102 proteins Nutrition 0.000 claims 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 claims 2
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 claims 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 claims 2
- 102000004196 processed proteins & peptides Human genes 0.000 claims 2
- 239000000126 substance Substances 0.000 claims 2
- 230000014616 translation Effects 0.000 claims 2
- 239000004474 valine Substances 0.000 claims 2
- RBCOYOYDYNXAFA-UHFFFAOYSA-L (5-hydroxy-4,6-dimethylpyridin-3-yl)methyl phosphate Chemical compound CC1=NC=C(COP([O-])([O-])=O)C(C)=C1O RBCOYOYDYNXAFA-UHFFFAOYSA-L 0.000 claims 1
- 206010007733 Catabolic state Diseases 0.000 claims 1
- FFEARJCKVFRZRR-UHFFFAOYSA-N L-Methionine Natural products CSCCC(N)C(O)=O FFEARJCKVFRZRR-UHFFFAOYSA-N 0.000 claims 1
- 235000019454 L-leucine Nutrition 0.000 claims 1
- 239000004395 L-leucine Substances 0.000 claims 1
- 125000003440 L-leucyl group Chemical group O=C([*])[C@](N([H])[H])([H])C([H])([H])C(C([H])([H])[H])([H])C([H])([H])[H] 0.000 claims 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 claims 1
- 229930195722 L-methionine Natural products 0.000 claims 1
- 241000124008 Mammalia Species 0.000 claims 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 claims 1
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 claims 1
- 229960002685 biotin Drugs 0.000 claims 1
- 235000020958 biotin Nutrition 0.000 claims 1
- 239000011616 biotin Substances 0.000 claims 1
- 230000037396 body weight Effects 0.000 claims 1
- FDJOLVPMNUYSCM-UVKKECPRSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2,7, Chemical compound [Co+3].N#[C-].C1([C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)[N-]\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O FDJOLVPMNUYSCM-UVKKECPRSA-L 0.000 claims 1
- 235000015872 dietary supplement Nutrition 0.000 claims 1
- 235000020776 essential amino acid Nutrition 0.000 claims 1
- 239000003797 essential amino acid Substances 0.000 claims 1
- 229960000304 folic acid Drugs 0.000 claims 1
- 235000019152 folic acid Nutrition 0.000 claims 1
- 239000011724 folic acid Substances 0.000 claims 1
- 238000001727 in vivo Methods 0.000 claims 1
- 239000004615 ingredient Substances 0.000 claims 1
- AGBQKNBQESQNJD-UHFFFAOYSA-M lipoate Chemical compound [O-]C(=O)CCCCC1CCSS1 AGBQKNBQESQNJD-UHFFFAOYSA-M 0.000 claims 1
- 235000019136 lipoic acid Nutrition 0.000 claims 1
- 229960004452 methionine Drugs 0.000 claims 1
- 210000003205 muscle Anatomy 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- IFGCUJZIWBUILZ-UHFFFAOYSA-N sodium 2-[[2-[[hydroxy-(3,4,5-trihydroxy-6-methyloxan-2-yl)oxyphosphoryl]amino]-4-methylpentanoyl]amino]-3-(1H-indol-3-yl)propanoic acid Chemical compound [Na+].C=1NC2=CC=CC=C2C=1CC(C(O)=O)NC(=O)C(CC(C)C)NP(O)(=O)OC1OC(C)C(O)C(O)C1O IFGCUJZIWBUILZ-UHFFFAOYSA-N 0.000 claims 1
- WPLOVIFNBMNBPD-ATHMIXSHSA-N subtilin Chemical compound CC1SCC(NC2=O)C(=O)NC(CC(N)=O)C(=O)NC(C(=O)NC(CCCCN)C(=O)NC(C(C)CC)C(=O)NC(=C)C(=O)NC(CCCCN)C(O)=O)CSC(C)C2NC(=O)C(CC(C)C)NC(=O)C1NC(=O)C(CCC(N)=O)NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C1NC(=O)C(=C/C)/NC(=O)C(CCC(N)=O)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)CNC(=O)C(NC(=O)C(NC(=O)C2NC(=O)CNC(=O)C3CCCN3C(=O)C(NC(=O)C3NC(=O)C(CC(C)C)NC(=O)C(=C)NC(=O)C(CCC(O)=O)NC(=O)C(NC(=O)C(CCCCN)NC(=O)C(N)CC=4C5=CC=CC=C5NC=4)CSC3)C(C)SC2)C(C)C)C(C)SC1)CC1=CC=CC=C1 WPLOVIFNBMNBPD-ATHMIXSHSA-N 0.000 claims 1
- JZRWCGZRTZMZEH-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 claims 1
- 229960002663 thioctic acid Drugs 0.000 claims 1
- 210000001519 tissue Anatomy 0.000 claims 1
- 239000011782 vitamin Substances 0.000 claims 1
- 235000013343 vitamin Nutrition 0.000 claims 1
- 229930003231 vitamin Natural products 0.000 claims 1
- 229940088594 vitamin Drugs 0.000 claims 1
- 150000003722 vitamin derivatives Chemical class 0.000 claims 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 239000005862 Whey Substances 0.000 description 2
- 102000007544 Whey Proteins Human genes 0.000 description 2
- 108010046377 Whey Proteins Proteins 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 1
- 229930182816 L-glutamine Natural products 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000003623 enhancer Substances 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 235000021590 normal diet Nutrition 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10/325,711 US7288570B2 (en) | 2002-12-20 | 2002-12-20 | Stimulation of in vivo production of proteins |
| PCT/NL2003/000892 WO2004056208A1 (en) | 2002-12-20 | 2003-12-15 | Stimulation of in vivo production of proteins with formulation comprising leucine |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2006510711A JP2006510711A (ja) | 2006-03-30 |
| JP2006510711A5 true JP2006510711A5 (enExample) | 2011-01-20 |
Family
ID=32593858
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2004562109A Pending JP2006510711A (ja) | 2002-12-20 | 2003-12-15 | ロイシンを含む組成物でタンパク質のインビボ生産を刺激する方法 |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US7288570B2 (enExample) |
| EP (1) | EP1455603B1 (enExample) |
| JP (1) | JP2006510711A (enExample) |
| CN (1) | CN100353866C (enExample) |
| AT (1) | ATE341226T1 (enExample) |
| AU (1) | AU2003290447B2 (enExample) |
| CA (1) | CA2510760C (enExample) |
| DE (1) | DE60308810T2 (enExample) |
| DK (1) | DK1455603T3 (enExample) |
| ES (1) | ES2274299T3 (enExample) |
| WO (1) | WO2004056208A1 (enExample) |
Families Citing this family (40)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4970694B2 (ja) * | 2002-12-02 | 2012-07-11 | 株式会社明治 | 持続性筋肉疲労改善剤 |
| US7288570B2 (en) * | 2002-12-20 | 2007-10-30 | Nutricia N.V. | Stimulation of in vivo production of proteins |
| ES2358045T3 (es) * | 2005-01-18 | 2011-05-05 | Dsm Ip Assets B.V. | Nuevas composiciones neutracéuticas. |
| EP1774973A1 (en) * | 2005-10-12 | 2007-04-18 | Nutricia N.V. | Leucine rich composition |
| EP1945044B1 (en) * | 2005-10-26 | 2009-04-15 | Hill's Pet Nutrition Inc. | Compositions for increasing lean muscle mass and/or reducing fat gain |
| ES2302463B1 (es) * | 2006-12-29 | 2009-06-05 | Madaus, S.A. | "composicion a base de fibra de cacao". |
| US8597677B2 (en) * | 2007-02-23 | 2013-12-03 | Hill's Pet Nutrition, Inc. | Compositions and methods for controlling the weight of animals |
| EP2098126A1 (en) * | 2008-03-03 | 2009-09-09 | Nestec S.A. | Carbohydrate Bar |
| EP2098124A1 (en) * | 2008-03-03 | 2009-09-09 | Nestec S.A. | Carbohydrate gel |
| PL2098125T3 (pl) * | 2008-03-03 | 2012-02-29 | Nestec Sa | Zżelowany produkt spożywczy z wysoką skutecznością przyjmowania węglowodanów |
| WO2010002242A1 (en) | 2008-07-02 | 2010-01-07 | N.V. Nutricia | Nutritional composition for improving muscle function and daily activity |
| EP2298090B1 (en) | 2009-08-26 | 2016-01-13 | Jeffrey M. Golini | Pharmaceutical or nutraceutical composition |
| EP2327316B1 (en) * | 2009-11-29 | 2016-11-16 | Premier Nutrition Corporation | Method of enhancing muscle protein synthesis |
| DK2327315T3 (da) * | 2009-11-29 | 2014-01-13 | Nestec Sa | Doseringsprotokoller til forøgelse af proteinsyntese i et aktivt individ |
| WO2011078654A1 (en) * | 2009-12-24 | 2011-06-30 | N.V. Nutricia | Low-caloric high-protein nutritional composition for the stimulation of muscle protein synthesis |
| AU2011214465A1 (en) | 2010-02-10 | 2012-08-30 | Novartis Ag | Methods and compounds for muscle growth |
| PH12012501759A1 (en) * | 2010-03-12 | 2012-11-12 | Nestec Sa | Compositions for masking the flavor of nutrients and methods for making same |
| WO2012005568A1 (en) * | 2010-07-07 | 2012-01-12 | N.V. Nutricia | Nutritional composition for the stimulation of muscle protein synthesis |
| RU2017129378A (ru) | 2011-07-15 | 2019-02-04 | Нусерт Сайенсиз, Инк. | Композиции и способы модулирования метаболических путей |
| US9198454B2 (en) | 2012-03-08 | 2015-12-01 | Nusirt Sciences, Inc. | Compositions, methods, and kits for regulating energy metabolism |
| JP2015518470A (ja) | 2012-03-26 | 2015-07-02 | プロニュートリア・インコーポレイテッドＰｒｏｎｕｔｒｉａ， Ｉｎｃ． | 栄養タンパク質および方法 |
| EP3715365A1 (en) * | 2012-03-26 | 2020-09-30 | Axcella Health Inc. | Nutritive fragments, proteins and methods |
| CA2868469A1 (en) | 2012-03-26 | 2013-10-03 | Pronutria, Inc. | Nutritive fragments, proteins and methods |
| WO2013148329A1 (en) | 2012-03-26 | 2013-10-03 | Pronutria, Inc. | Charged nutritive proteins and methods |
| AU2013344753B2 (en) | 2012-11-13 | 2018-09-27 | Nusirt Sciences, Inc. | Compositions and methods for increasing energy metabolism |
| CA2902879C (en) | 2013-03-15 | 2023-09-26 | Nusirt Sciences, Inc. | Leucine and nicotinic acid reduces lipid levels |
| US9597367B2 (en) | 2013-04-19 | 2017-03-21 | Bioventures, Llc | Methods for improving muscle and heart function |
| CN112931879A (zh) * | 2013-06-10 | 2021-06-11 | N·V·努特里奇亚 | 超重或肥胖成年人在体重减轻项目期间的肌肉保持 |
| MX2016003944A (es) | 2013-09-25 | 2016-12-09 | Pronutria Biosciences Inc | Composiciones y formulaciones para mantener y aumentar la masa muscular, fuerza y rendimiento y metodos de produccion y usos de los mismos. |
| CN106456997B (zh) | 2014-02-27 | 2018-12-28 | 纽斯尔特科学公司 | 用于减少或预防肝性脂肪变性的组合物和方法 |
| JP6585060B2 (ja) | 2014-08-29 | 2019-10-02 | 株式会社レナサイエンス | ピリドキサミン化合物及びチアミン化合物を組み合わせてなる医薬組成物 |
| US10188135B2 (en) * | 2015-11-04 | 2019-01-29 | Stokley-Van Camp, Inc. | Method for inducing satiety |
| RU2601406C1 (ru) * | 2015-11-17 | 2016-11-10 | Государственное Бюджетное Образовательное Учреждение Высшего Профессионального Образования "Саратовский Государственный Медицинский Университет Имени В.И. Разумовского" Министерства Здравоохранения Российской Федерации | Средство, обладающее антикахексическим, противоопухолевым свойствами и снижающее уровень эндогенной интоксикации |
| JP6105111B1 (ja) | 2016-03-02 | 2017-03-29 | 国立大学法人東北大学 | 自閉スペクトラム症改善用組成物 |
| JOP20190146A1 (ar) | 2016-12-19 | 2019-06-18 | Axcella Health Inc | تركيبات حمض أميني وطرق لمعالجة أمراض الكبد |
| CN111295187A (zh) | 2017-08-14 | 2020-06-16 | 胺细拉健康公司 | 用于治疗肝脏疾病的氨基酸组合物 |
| CH714189A1 (de) * | 2017-09-25 | 2019-03-29 | Omanda Ag | Verfahren zur Herstellung von L-Leucin und Molkenprotein L-Leucin zur Nahrungsanreicherung und dessen Anwendung. |
| JP7529566B2 (ja) | 2017-11-02 | 2024-08-06 | バイオベンチャーズ・リミテッド・ライアビリティ・カンパニー | 筋タンパク質合成を改善するためのアミノ酸補給の使用 |
| MA52971A (fr) | 2018-06-20 | 2021-04-28 | Axcella Health Inc | Compositions et procédés pour le traitement de l'infiltration de graisse dans le muscle |
| CH715997A1 (de) * | 2019-03-25 | 2020-09-30 | Omanda Ag | Proteingetränk und Darreichungseinheit zur Verabreichung von mit L-Leucin-angereicherten Molkenproteinkomponenten als Nahrungsanreicherung und dessen Herstellung. |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3928445A (en) * | 1973-12-26 | 1975-12-23 | Allied Chem | Synthesis of 2-halo-5-cyano alkyl valerate |
| JPS6049764A (ja) * | 1983-08-29 | 1985-03-19 | Ajinomoto Co Inc | 食品組成物 |
| JPS60186261A (ja) * | 1984-03-06 | 1985-09-21 | Ajinomoto Co Inc | 固体状食品組成物 |
| US4687782A (en) | 1984-12-10 | 1987-08-18 | Nutri-Fuels Systems, Inc. | Nutritional composition for enhancing skeletal muscle adaptation to exercise training |
| US5639731A (en) * | 1987-05-22 | 1997-06-17 | Pripps Bryggerier Ab | Amino acids for the preparation of a beverage |
| FI892006A7 (fi) * | 1988-04-29 | 1989-10-30 | Phil Gold | Laktalbumiini ruoan lisäaineena |
| US5242697A (en) | 1990-10-26 | 1993-09-07 | Maurizio Luca | Method of preparing nutrified food products |
| JP3622271B2 (ja) | 1995-07-11 | 2005-02-23 | 味の素株式会社 | 馬用栄養組成物 |
| US5817329A (en) * | 1997-02-28 | 1998-10-06 | Gardiner; Paul T. | Nutritional supplement for increased muscle size and strength for body builders |
| IT1291127B1 (it) | 1997-04-01 | 1998-12-29 | Sigma Tau Ind Farmaceuti | Integratore alimentare per soggetti dediti ad intensa e prolungata attivita' fisica |
| DE29707308U1 (de) | 1997-04-23 | 1997-06-26 | Kunz, Armin, 66450 Bexbach | Präparat zur Muskelerhaltung bzw. zur Förderung des Muskelaufbaus |
| US6051236A (en) * | 1998-11-12 | 2000-04-18 | Pacifichealth Laboratories, Inc. | Composition for optimizing muscle performance during exercise |
| US6221418B1 (en) * | 1999-03-25 | 2001-04-24 | Focused Foods, Inc. | High protein edible composition and method of preparing the same |
| US6241996B1 (en) * | 1999-04-09 | 2001-06-05 | Novartis Nutrition Ag | Liquid soy nutritional products |
| EP1112693B1 (en) | 1999-12-30 | 2006-03-22 | Kerry Group Services Ltd | Composition comprising carbohydrate and peptide material and its use as an energy supplement after or during physical exercise or as a metabolic nutrient for oral consumption |
| US6521591B1 (en) | 2000-02-10 | 2003-02-18 | N.V. Nutricia | Pharmaceutical composition for muscular anabolism |
| US6420342B1 (en) * | 2000-05-08 | 2002-07-16 | N.V. Nutricia | Nutritional preparation comprising ribose and medical use thereof |
| US6706295B2 (en) * | 2000-09-29 | 2004-03-16 | The Procter & Gamble Co. | Compositions comprising arabinogalactan and a defined protein component |
| GB0110288D0 (en) | 2001-04-26 | 2001-06-20 | Novartis Nutrition Ag | Composition and treatment method |
| US7288570B2 (en) * | 2002-12-20 | 2007-10-30 | Nutricia N.V. | Stimulation of in vivo production of proteins |
-
2002
- 2002-12-20 US US10/325,711 patent/US7288570B2/en not_active Expired - Lifetime
-
2003
- 2003-12-15 AU AU2003290447A patent/AU2003290447B2/en not_active Ceased
- 2003-12-15 CA CA2510760A patent/CA2510760C/en not_active Expired - Fee Related
- 2003-12-15 ES ES03782981T patent/ES2274299T3/es not_active Expired - Lifetime
- 2003-12-15 DE DE60308810T patent/DE60308810T2/de not_active Expired - Lifetime
- 2003-12-15 CN CNB2003801098651A patent/CN100353866C/zh not_active Expired - Lifetime
- 2003-12-15 WO PCT/NL2003/000892 patent/WO2004056208A1/en not_active Ceased
- 2003-12-15 DK DK03782981T patent/DK1455603T3/da active
- 2003-12-15 AT AT03782981T patent/ATE341226T1/de active
- 2003-12-15 EP EP03782981A patent/EP1455603B1/en not_active Expired - Lifetime
- 2003-12-15 JP JP2004562109A patent/JP2006510711A/ja active Pending
-
2007
- 2007-10-16 US US11/872,804 patent/US20080161398A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2006510711A5 (enExample) | ||
| ES2622116T3 (es) | Composición nutricional para la estimulación de la síntesis de proteínas musculares | |
| CA2221455C (en) | Pharmaceutical and/or dietetic compositions with antioxidant activity containing carnosine or derivatives and branched amino acids | |
| CA2510760A1 (en) | Stimulation of in vivo production of proteins with formulation comprising leucine | |
| US6521591B1 (en) | Pharmaceutical composition for muscular anabolism | |
| CA2845829A1 (en) | Compositions and methods for use in promoting lean body mass | |
| JP4928473B2 (ja) | グアニジノ酢酸の塩、付加化合物及び錯化合物 | |
| JP2024122087A (ja) | 遊離アミノ酸吸収促進剤及び遊離アミノ酸の吸収を促進する方法 | |
| JP2002065212A (ja) | 筋強化用食品組成物及び筋強化剤 | |
| WO2021004913A1 (en) | Compositions and methods using trigonelline and high protein for preventing or treating conditions or disorders in skeletal muscle | |
| JP5922863B2 (ja) | 運動機能改善剤 | |
| JP5980519B2 (ja) | Ａｍｐｋ活性化剤 | |
| CA3140733A1 (en) | Compositions and methods using trigonelline and minerals for preventing or treating conditions or disorders in skeletal muscle | |
| HK1104782B (en) | Use of the salts, addition compounds and complex compounds of guanidinoacetic acid | |
| HK1065447B (en) | Stimulation of in vivo production of proteins with formulation comprising leucine |